From doctors’ offices to film screenings to dining room tables, women are talking about their changing bodies during ...

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

The contrast between the FDA's clinical lens and the raw realities in the Bonafide study highlights a critical disconnect that while the government fine-tunes regulatory pathways for hormone therapy, ...

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading ...

Recent new studies refute longtime claims that hormone therapy is risky business. Remember all that scary news?

Pedro C. Barata, MD, MSc, discusses the advantages and disadvantages of darolutamide in metastatic hormone-sensitive prostate cancer.

Here’s what experts say you should know about DIM, "good" estrogens and the future of hormone support in midlife and beyond. That ‘Natural’ Supplement Might Be Messing With Your Hormones DIM is a ...

Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

From celebrity talk shows to social feeds, it may feel like everyone is talking about perimenopause and menopause these days.

At the intersection of aesthetics and science, RegenCen is changing how patients think about aging. Born from a fusion of ...

Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.